Lastacaft

Active Ingredient(s): Alcaftadine
FDA Approved: * July 28, 2010
Pharm Company: * VISTAKON PHARMA
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Lastacaft Overview

Alcaftadine is used to prevent eye irritation brought on by allergic conjunctivitis. It is a H1 histamine receptor antagonist.[1] It was approved by the U.S. Food and Drug Administration in 2010 under the trade name Lastacaft. Contents 1 Pharmacology 2 Clinical relevance 3 Adverse effects 4 Pharmacokinetics 5 Sales 6 See also 7 References 8 External links Pharmacology Alcaftadine is an antagonist at three of the histamine receptors (1, 2 and 4). The main indication fo...

Read more Lastacaft Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alcaftadine

Recent Lastacaft Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Alcaftadine

Solution/drops: 0.25%

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lastacaft: (3 results)

Sorted by National Drug Code

0023-4290 Lastacaft 2.5 mg/ml Ophthalmic Solution/ Drops by Allergan, Inc.
42254-288 Lastacaft 2.5 mg/ml Ophthalmic Solution/ Drops by Rebel Distributors Corp
54868-6294 Lastacaft 2.5 mg/ml Ophthalmic Solution/ Drops by Physicians Total Care, Inc.

Other drugs which contain Alcaftadine or a similar ingredient: (1 result)

ALCAFTADINE